Sera Prognostics Stock
Sera Prognostics, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Zhenya Lindgardt
- Employees
- 72
- Market cap
- $79 M
- IPO
- 15/07/2021
- Web
- www.sera.com
Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm…
Sera Prognostics stock: price history
1D
+1.5%
1W
+1.0%
1M
+2.0%
6M
-10.4%
YTD
-30.2%
1Y
-38.3%
2Y
-74.1%
5Y
-81.0%
10Y
–
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~21% weaker price swings than usual
Ask the agents about Sera Prognostics
Analyst assessment of Sera Prognostics
PRICE TARGET LOW
US$6.00
CONSENSUS
US$6.00
MEDIAN
US$6.00
PRICE TARGET HIGH
US$6.00
0
STRONG BUY
4
BUY
1
HOLD
0
SELL
0
STRONG SELL
5
TOTAL · Buy
As of: 10/08/2023
Sera Prognostics stock metrics
P/E
-3.07
P/B
1.75
EV/EBITDA
-2.41
RETURN ON EQUITY
-15.4%
NET MARGIN
-30,463.3%
DEBT/EQUITY
0.05
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
72.0%
FLOAT SHARES
27,700,626
AVG. DAILY VOLUME (30D)
18,294
Insider transactions (SEC)
Inglis Tiffany Eul Davis
Inglis Tiffany Eul Davis
Anderson Dyaarl Lee Jr.
Lindgardt Zhenya
Jackson Benjamin
Institutional holders
Comparable stocks
Frequently asked questions about Sera Prognostics stock
What does Sera Prognostics do?
Sera Prognostics, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Zhenya Lindgardt, the company employs around 72 people.
The IPO was on 15/07/2021; the stock trades on NASDAQ under the ticker SERA.
What do analysts say about Sera Prognostics stock?
5 analysts rate the stock, the consensus is Buy (as of 10/08/2023).
The average price target is US$6.00, ranging from US$6.00 to US$6.00, with a median of US$6.00.
This is an external assessment, not a statement by Market Jury.
When does Sera Prognostics report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly -21% stronger than usual.
Does Sera Prognostics pay a dividend?
No, Sera Prognostics currently does not pay a dividend.
Which stocks are comparable to Sera Prognostics?
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and IDEXX Laboratories.
How can I get Sera Prognostics stock analyzed?
Clicking "Analyze stock" lets five strategies assess Sera Prognostics against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.